Position in PTGX
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$24,352,722
+$7,624,584 QoQ
Shares Held
198,668
+25.2% QoQ
Ownership
0.307%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#48
of 341 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Derivatives in PTGX
reported options exposure · as of Mar 31, 2023CallValue
$584,200
CallShares
25,400
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITIGROUP INC holds $2,077,377,990 across 384 Biotechnology names. PTGX ranks #17 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
706,968 | $351,172,214 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
346,637 | $216,142,034 | |
| 3 | MRNA |
Moderna, Inc.
|
2,165,414 | $151,643,941 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
2,225,190 | $78,749,472 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
227,786 | $68,570,419 | |
| 6 | INCY |
Incyte Corp
|
586,431 | $66,477,817 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
864,101 | $64,358,241 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
247,052 | $46,267,897 |
All Filings in PTGX
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,352,722 | 198,668 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $16,728,138 | 158,711 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $8,289,351 | 94,909 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $10,135,887 | 152,580 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $4,308,350 | 77,951 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $5,892,374 | 121,844 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $4,671,448 | 121,022 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $3,307,050 | 73,490 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $728,169 | 21,015 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $6,035,983 | 208,641 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $1,667,079 | 72,703 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $2,465,770 | 147,828 | Shares | Defined | 2023-12-06 | |
| 2023-06-30 | $2,969,729 | 107,521 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $584,200 | 25,400 | Call | Defined | 2023-05-11 | |
| 2023-03-31 | $4,424,027 | 192,349 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $1,615,421 | 148,068 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $2,657,085 | 315,194 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $2,511,416 | 317,499 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $844,332 | 35,656 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $4,711,084 | 137,751 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $906,998 | 51,185 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $3,255,594 | 72,540 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $2,479,148 | 95,720 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $195,693 | 9,707 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $47,135 | 2,411 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,139,900 | 64,547 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $49,575 | 7,022 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||